Whitehawk Therapeutics, Inc. (WHWK)
2025-06-30 | 2025-03-31 | |||
|---|---|---|---|---|
| Total revenue | - | 7,145 | ||
| Total revenue-Product | - | - | ||
| Selling, general and administrative | 5,940 | 12,815 | ||
| Research and development | 48,809 | 8,788 | ||
| Cost of goods sold | - | 760 | ||
| Total operating expenses | 54,749 | 22,363 | ||
| Loss from operations | -54,749 | -15,218 | ||
| Other income | 158 | - | ||
| Interest income | 1,979 | 791 | ||
| Interest expense | - | - | ||
| Gain on sale of business | - | 87,443 | ||
| Foreign exchange loss | -3 | - | ||
| Total other income (expense), net | 2,134 | 88,234 | ||
| Net (loss) income | -52,615 | 73,016 | ||
| Unrealized gain (loss) on investments, net of tax | 8 | - | ||
| Unrealized loss on investments, net of tax | - | -15 | ||
| Comprehensive (loss) income | -52,607 | 73,001 | ||
| Earnings per share, basic | -0.76 | 1.84 | ||
| Earnings per share, diluted | -0.76 | 1.83 | ||
| Weighted average number of shares outstanding, basic | 69,083,127 | 39,640,826 | ||
| Weighted average number of shares outstanding, diluted | 69,083,127 | 39,932,539 | ||